Valuation: USANA Health Sciences, Inc.

Market Cap 287M 255M 237M 215M 406M 27.25B 413M 2.84B 1.11B 14.22B 1.08B 1.05B 45.33B P/E 2026 *
-25.5x
P/E 2027 * 12x
Enterprise Value 287M 255M 237M 215M 406M 27.25B 413M 2.84B 1.11B 14.22B 1.08B 1.05B 45.33B EV / Sales 2026 *
0.32x
EV / Sales 2027 * 0.3x
Free-Float
59.12%
Yield 2026 *
-
Yield 2027 * -
1 day+1.04%
1 week+6.00%
Current month+7.39%
1 month+8.37%
3 months-28.78%
6 months-22.53%
Current year-20.84%
1 week 14.46
Extreme 14.455
15.99
1 month 14
Extreme 14
15.99
Current year 12.57
Extreme 12.57
23.59
1 year 12.57
Extreme 12.57
23.59
3 years 12.57
Extreme 12.57
57.78
5 years 12.57
Extreme 12.57
103.95
10 years 12.57
Extreme 12.57
137.95
Manager TitleAgeSince
Chief Executive Officer 63 2026-01-07
Director of Finance/CFO 56 2017-04-30
Chief Tech/Sci/R&D Officer 45 2024-06-30
Director TitleAgeSince
Director/Board Member 77 2019-10-22
Chairman 63 2020-04-30
Chairman 85 1992-08-31
Date Insider Type Main position Quantity % Market Cap. Importance
7/25/26 Exercice

CHIEF INFORMATION OFFICER

1,372 0.0074% -
7/25/26 Exercice

Chief Technology Officer

2,850 0.0154%
7/23/26 Exercice

Director

3,672 0.0199%
Change 5-day change 1-year change 3-year change Capi.($)
+1.04%+6.00%-25.61%-72.65% 287M
+1.68%+8.40%-2.83%-19.80% 257B
+1.40%+5.79%+2.32%+0.58% 81.57B
0.00%+0.08%+22.14%+540.13% 45.82B
+0.56%+4.87%-20.59%+13.08% 44.55B
-0.39%+3.40%+30.44%+9.85% 39.81B
+1.27%+4.97%-9.01%-10.45% 34.32B
+0.82%-2.20%+26.74%+84.36% 31.92B
+0.70%+2.82%-11.41%-5.10% 29.68B
+1.72%+6.33%-7.21%-24.85% 28.08B
Average +0.88%+3.70%+0.50%+51.51% 59.34B
Weighted average by Cap. +1.17%+5.43%+1.29%+37.31%

Financials

2026 *2027 *
Net sales 909M 808M 749M 681M 1.29B 86.27B 1.31B 9B 3.53B 45.02B 3.41B 3.34B 144B 945M 840M 779M 708M 1.34B 89.69B 1.36B 9.36B 3.67B 46.8B 3.55B 3.47B 149B
Net income -11.24M -9.99M -9.26M -8.42M -15.89M -1.07B -16.15M -111M -43.63M -556M -42.17M -41.27M -1.77B 23.8M 21.15M 19.61M 17.84M 33.66M 2.26B 34.2M 236M 92.41M 1.18B 89.32M 87.42M 3.76B
Net Debt - -
Projected Income Statement - Annual - USANA Health Sciences, Inc.
Logo USANA Health Sciences, Inc.
USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures nutritional supplements, functional foods and personal care products. Its segments include Core nutritional and Hiya direct-to-consumer. The Core nutritional segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the core nutritional channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal care and Skincare, and All other. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3.
Employees
1,570
Date Price Change Volume
26-10-16 US$15.54 +1.04% 211,706
26-10-15 US$15.38 +0.72% 184,792
26-10-14 US$15.27 -1.23% 236,365
26-10-13 US$15.46 +3.41% 288,269
26-10-12 US$14.95 +1.98% 209,664
Trader
-
Investor
Global
-
Quality
ESG MSCI
BBB
MarketScreener Ratings - USANA Health Sciences, Inc.

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - USANA Health Sciences, Inc.
  1. Stock Market
  2. Stocks
  3. USNA Stock